Skip to content

Clinical trials

Active, not recruiting Neoplasm Metastasis trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Status: Active, not recruiting Country / region: Germany Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20131
20151
20163
20181
20192
20203
202111
20229
20231
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting36

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca9
Eli Lilly and Company5
Novartis Pharmaceuticals3
AbbVie2
Bristol-Myers Squibb2
BioInvent International AB1
BioNTech SE1
Boehringer Ingelheim1
Celcuity Inc1
Genentech, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis36
Breast Neoplasms9
Carcinoma, Non-Small-Cell Lung8
Neoplasms7
Colorectal Neoplasms5
Breast Diseases3
Melanoma3
Prostatic Neoplasms3
Carcinoma2
Colonic Neoplasms2

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.